The approvals stem from the Phase III KEYNOTE-B96 trial data, which was presented at the 2025 ESMO Congress.

But now, 13 years after the FDA initially blessed it for skin cancer, the U.S. regulator has approved Keytruda as a second- ...

Italian model Bianca Balti was diagnosed with ovarian cancer in 2024. One year after finishing her last round of chemotherapy ...

Mayo Clinic researchers say they have discovered that ovarian cancer cells can quickly activate a survival response after treatment with PARP inhibitors.

Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to chemotherapy, offering insight into why cancers recur. The study, published ...

A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response ...

A companion diagnostic test was simultaneously approved to identify eligible patients whose tumors express PD-L1 with a combined positive score of 1 or higher.

Canadian figure skater Piper Gilles survived ovarian cancer before winning a bronze medal in ice dance at the 2026 Winter Olympics. She shares her symptoms.

Premenopausal women would benefit from a significantly more accurate diagnostic pathway for ovarian cancer, as a new study ...

Ovarian cancer no longer just for older women as cases rise among those under 40. Dr Kanika Batra Modi, Associate Director and Clinical Lead – Gynaecological Oncology, Max Super Speciality Hospital, ...

FDA approves pembrolizumab with chemotherapy for platinum-resistant ovarian cancer, showing significant survival benefits in ...